The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...
Zacks Investment Research on MSN
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. According to Grand View Research, the market ...
Ian Harris receives funding from research organisations unrelated to spinal cord stimulators. He was interviewed for the Four Corners episode referred to. Adrian C Traeger receives research funding ...
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
(Reuters) -Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, expanding its portfolio of treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback